Sign in
4

Changes in Ownership

ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-21-040891

Options or other derivatives

  • General Counsel acquired 100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Wilson Martin · General Counsel

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-12-06 Grant or award : show line 1 in the form Stock Option (Right to Buy) +100,000 $23.04 2031-12-06 100,000 100,000 D
Loading xslF345X03/form4.xml…